Global Phage Display Service 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06254002

Publication Date:

June 20, 2025

Pages:

150

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Phage Display Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Phage Display Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Phage Display Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Phage Display Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Phage Display Service players cover Creative Biogene, Creative Biolabs, ProteoGenix, CUSABIO, Diaclone, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧hage Display Service Industry Forecast鈥� looks at past sales and reviews total world Phage Display Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Phage Display Service sales for 2025 through 2031. With Phage Display Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phage Display Service industry.
This Insight Report provides a comprehensive analysis of the global Phage Display Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Phage Display Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Phage Display Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phage Display Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phage Display Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Phage Display Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
cDNA Library
Antibody Library
Protein Library
Random Peptide Library
Segmentation by Application:
Immunotherapy
Drug Discovery
Functional Genomics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Biogene
Creative Biolabs
ProteoGenix
CUSABIO
Diaclone
Biomolecular Discovery Services
Charles River
GenScript
Synbio Technologies
Creative Peptides
ProImmune
Absolute Antibody
Iontas
LakePharma
KMD Bioscience
NeoClone
Pepscan
Abzena
ChemPartner
Creative Proteomics
Yntoab
Diane biological
Biosynth
Zoonbio Biotechnology
Abiocenter

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Phage Display Service 麻豆原创 Size (2020-2031)
2.1.2 Phage Display Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Phage Display Service by Country/Region (2020, 2024 & 2031)
2.2 Phage Display Service Segment by Type
2.2.1 cDNA Library
2.2.2 Antibody Library
2.2.3 Protein Library
2.2.4 Random Peptide Library
2.3 Phage Display Service 麻豆原创 Size by Type
2.3.1 Phage Display Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Phage Display Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Phage Display Service Segment by Application
2.4.1 Immunotherapy
2.4.2 Drug Discovery
2.4.3 Functional Genomics
2.4.4 Others
2.5 Phage Display Service 麻豆原创 Size by Application
2.5.1 Phage Display Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Phage Display Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Phage Display Service 麻豆原创 Size by Player
3.1 Phage Display Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Phage Display Service Revenue by Player (2020-2025)
3.1.2 Global Phage Display Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Phage Display Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Phage Display Service by Region
4.1 Phage Display Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Phage Display Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Phage Display Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Phage Display Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Phage Display Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Phage Display Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Phage Display Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Phage Display Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Phage Display Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phage Display Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Phage Display Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Phage Display Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Phage Display Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Phage Display Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Phage Display Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Phage Display Service by Region (2020-2025)
8.2 Middle East & Africa Phage Display Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Phage Display Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Phage Display Service 麻豆原创 Forecast
10.1 Global Phage Display Service Forecast by Region (2026-2031)
10.1.1 Global Phage Display Service Forecast by Region (2026-2031)
10.1.2 Americas Phage Display Service Forecast
10.1.3 APAC Phage Display Service Forecast
10.1.4 Europe Phage Display Service Forecast
10.1.5 Middle East & Africa Phage Display Service Forecast
10.2 Americas Phage Display Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Phage Display Service Forecast
10.2.2 Canada 麻豆原创 Phage Display Service Forecast
10.2.3 Mexico 麻豆原创 Phage Display Service Forecast
10.2.4 Brazil 麻豆原创 Phage Display Service Forecast
10.3 APAC Phage Display Service Forecast by Region (2026-2031)
10.3.1 China Phage Display Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Phage Display Service Forecast
10.3.3 Korea 麻豆原创 Phage Display Service Forecast
10.3.4 Southeast Asia 麻豆原创 Phage Display Service Forecast
10.3.5 India 麻豆原创 Phage Display Service Forecast
10.3.6 Australia 麻豆原创 Phage Display Service Forecast
10.4 Europe Phage Display Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Phage Display Service Forecast
10.4.2 France 麻豆原创 Phage Display Service Forecast
10.4.3 UK 麻豆原创 Phage Display Service Forecast
10.4.4 Italy 麻豆原创 Phage Display Service Forecast
10.4.5 Russia 麻豆原创 Phage Display Service Forecast
10.5 Middle East & Africa Phage Display Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Phage Display Service Forecast
10.5.2 South Africa 麻豆原创 Phage Display Service Forecast
10.5.3 Israel 麻豆原创 Phage Display Service Forecast
10.5.4 Turkey 麻豆原创 Phage Display Service Forecast
10.6 Global Phage Display Service Forecast by Type (2026-2031)
10.7 Global Phage Display Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Phage Display Service Forecast
11 Key Players Analysis
11.1 Creative Biogene
11.1.1 Creative Biogene Company Information
11.1.2 Creative Biogene Phage Display Service Product Offered
11.1.3 Creative Biogene Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Creative Biogene Main Business Overview
11.1.5 Creative Biogene Latest Developments
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Information
11.2.2 Creative Biolabs Phage Display Service Product Offered
11.2.3 Creative Biolabs Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Creative Biolabs Main Business Overview
11.2.5 Creative Biolabs Latest Developments
11.3 ProteoGenix
11.3.1 ProteoGenix Company Information
11.3.2 ProteoGenix Phage Display Service Product Offered
11.3.3 ProteoGenix Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 ProteoGenix Main Business Overview
11.3.5 ProteoGenix Latest Developments
11.4 CUSABIO
11.4.1 CUSABIO Company Information
11.4.2 CUSABIO Phage Display Service Product Offered
11.4.3 CUSABIO Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 CUSABIO Main Business Overview
11.4.5 CUSABIO Latest Developments
11.5 Diaclone
11.5.1 Diaclone Company Information
11.5.2 Diaclone Phage Display Service Product Offered
11.5.3 Diaclone Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Diaclone Main Business Overview
11.5.5 Diaclone Latest Developments
11.6 Biomolecular Discovery Services
11.6.1 Biomolecular Discovery Services Company Information
11.6.2 Biomolecular Discovery Services Phage Display Service Product Offered
11.6.3 Biomolecular Discovery Services Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Biomolecular Discovery Services Main Business Overview
11.6.5 Biomolecular Discovery Services Latest Developments
11.7 Charles River
11.7.1 Charles River Company Information
11.7.2 Charles River Phage Display Service Product Offered
11.7.3 Charles River Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Charles River Main Business Overview
11.7.5 Charles River Latest Developments
11.8 GenScript
11.8.1 GenScript Company Information
11.8.2 GenScript Phage Display Service Product Offered
11.8.3 GenScript Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 GenScript Main Business Overview
11.8.5 GenScript Latest Developments
11.9 Synbio Technologies
11.9.1 Synbio Technologies Company Information
11.9.2 Synbio Technologies Phage Display Service Product Offered
11.9.3 Synbio Technologies Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Synbio Technologies Main Business Overview
11.9.5 Synbio Technologies Latest Developments
11.10 Creative Peptides
11.10.1 Creative Peptides Company Information
11.10.2 Creative Peptides Phage Display Service Product Offered
11.10.3 Creative Peptides Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Creative Peptides Main Business Overview
11.10.5 Creative Peptides Latest Developments
11.11 ProImmune
11.11.1 ProImmune Company Information
11.11.2 ProImmune Phage Display Service Product Offered
11.11.3 ProImmune Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 ProImmune Main Business Overview
11.11.5 ProImmune Latest Developments
11.12 Absolute Antibody
11.12.1 Absolute Antibody Company Information
11.12.2 Absolute Antibody Phage Display Service Product Offered
11.12.3 Absolute Antibody Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Absolute Antibody Main Business Overview
11.12.5 Absolute Antibody Latest Developments
11.13 Iontas
11.13.1 Iontas Company Information
11.13.2 Iontas Phage Display Service Product Offered
11.13.3 Iontas Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Iontas Main Business Overview
11.13.5 Iontas Latest Developments
11.14 LakePharma
11.14.1 LakePharma Company Information
11.14.2 LakePharma Phage Display Service Product Offered
11.14.3 LakePharma Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 LakePharma Main Business Overview
11.14.5 LakePharma Latest Developments
11.15 KMD Bioscience
11.15.1 KMD Bioscience Company Information
11.15.2 KMD Bioscience Phage Display Service Product Offered
11.15.3 KMD Bioscience Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 KMD Bioscience Main Business Overview
11.15.5 KMD Bioscience Latest Developments
11.16 NeoClone
11.16.1 NeoClone Company Information
11.16.2 NeoClone Phage Display Service Product Offered
11.16.3 NeoClone Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 NeoClone Main Business Overview
11.16.5 NeoClone Latest Developments
11.17 Pepscan
11.17.1 Pepscan Company Information
11.17.2 Pepscan Phage Display Service Product Offered
11.17.3 Pepscan Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Pepscan Main Business Overview
11.17.5 Pepscan Latest Developments
11.18 Abzena
11.18.1 Abzena Company Information
11.18.2 Abzena Phage Display Service Product Offered
11.18.3 Abzena Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Abzena Main Business Overview
11.18.5 Abzena Latest Developments
11.19 ChemPartner
11.19.1 ChemPartner Company Information
11.19.2 ChemPartner Phage Display Service Product Offered
11.19.3 ChemPartner Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 ChemPartner Main Business Overview
11.19.5 ChemPartner Latest Developments
11.20 Creative Proteomics
11.20.1 Creative Proteomics Company Information
11.20.2 Creative Proteomics Phage Display Service Product Offered
11.20.3 Creative Proteomics Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Creative Proteomics Main Business Overview
11.20.5 Creative Proteomics Latest Developments
11.21 Yntoab
11.21.1 Yntoab Company Information
11.21.2 Yntoab Phage Display Service Product Offered
11.21.3 Yntoab Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 Yntoab Main Business Overview
11.21.5 Yntoab Latest Developments
11.22 Diane biological
11.22.1 Diane biological Company Information
11.22.2 Diane biological Phage Display Service Product Offered
11.22.3 Diane biological Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.22.4 Diane biological Main Business Overview
11.22.5 Diane biological Latest Developments
11.23 Biosynth
11.23.1 Biosynth Company Information
11.23.2 Biosynth Phage Display Service Product Offered
11.23.3 Biosynth Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.23.4 Biosynth Main Business Overview
11.23.5 Biosynth Latest Developments
11.24 Zoonbio Biotechnology
11.24.1 Zoonbio Biotechnology Company Information
11.24.2 Zoonbio Biotechnology Phage Display Service Product Offered
11.24.3 Zoonbio Biotechnology Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.24.4 Zoonbio Biotechnology Main Business Overview
11.24.5 Zoonbio Biotechnology Latest Developments
11.25 Abiocenter
11.25.1 Abiocenter Company Information
11.25.2 Abiocenter Phage Display Service Product Offered
11.25.3 Abiocenter Phage Display Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.25.4 Abiocenter Main Business Overview
11.25.5 Abiocenter Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.